Champions Oncology, Inc. operates as a global contract research organization (CRO) specializing in oncology. The company provides end-to-end research and development solutions, focusing on accelerating the development of cancer therapeutics through patient-derived models and advanced analytical platforms. Its services include preclinical and clinical studies, leveraging a large collection of patient-derived xenograft (PDX) models and extensive molecular datasets. Champions Oncology serves pharmaceutical and biotechnology companies worldwide, aiming to enhance drug development processes and improve patient outcomes.
- Website
- championsoncology.com
- Issuer profile
- All listings